These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20921091)

  • 1. Antithrombotic therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Cequier ÁR; Angiolillo DJ
    Diab Vasc Dis Res; 2010 Oct; 7(4):274-88. PubMed ID: 20921091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.
    Ferreiro JL; Cequier AR; Angiolillo DJ
    Trends Cardiovasc Med; 2010 Oct; 20(7):211-7. PubMed ID: 22293020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.
    Capranzano P; Capodanno D
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):307-17. PubMed ID: 23469911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease.
    Farhan S; Höchtl T; Wojta J; Huber K
    Minerva Med; 2010 Aug; 101(4):239-53. PubMed ID: 21030936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
    Ferreiro JL; Angiolillo DJ
    Curr Pharm Des; 2012; 18(33):5273-93. PubMed ID: 22724415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2020 Dec; 142(22):2172-2188. PubMed ID: 33253005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.
    Packard KA; Campbell JA; Knezevich JT; Davis EM
    Pharmacotherapy; 2012 Mar; 32(3):244-73. PubMed ID: 22392457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of antithrombotic drugs in coronary artery disease.
    Fauler J
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):465-78. PubMed ID: 19726525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state-of-the-art antiplatelet and anticoagulation therapy in diabetic patients with coronary artery disease.
    Nicolas J; Razuk V; Giustino G; Mehran R
    Future Cardiol; 2021 May; 17(3):521-534. PubMed ID: 33728965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of race and gender on antithrombotic therapy.
    Capodanno D; Angiolillo DJ
    Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study.
    Guan S; Xu X; Li Y; Li J; Guan M; Wang X; Jing Q; Huo Y; Han Y
    J Am Heart Assoc; 2020 Nov; 9(22):e013476. PubMed ID: 33164633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotics in atrial fibrillation and coronary disease.
    Velagapudi P; Turagam MK; Agrawal H; Mittal M; Kocheril AG; Aggarwal K
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):977-86. PubMed ID: 25046150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
    Serebruany V; Pokov I; Kuliczkowski W; Chesebro J; Badimon J
    Thromb Haemost; 2008 Jul; 100(1):76-82. PubMed ID: 18612541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy for Secondary Prevention in Patients With Diabetes Mellitus and Coronary Artery Disease.
    Park Y; Franchi F; Rollini F; Angiolillo DJ
    Circ J; 2016; 80(4):791-801. PubMed ID: 26984587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
    De Luca L; Bonaca MP; Magnani G
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern antiplatelet agents in coronary artery disease.
    Power RF; Hynes BG; Moran D; Yagoub H; Kiernan G; Ruggiero NJ; Kiernan TJ
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1261-72. PubMed ID: 23190065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
    Cannon CP; Rhee KE; Califf RM; Boden WE; Hirsch AT; Alberts MJ; Cable G; Shao M; Ohman EM; Steg PG; Eagle KA; Bhatt DL;
    Am J Cardiol; 2010 Feb; 105(4):445-52. PubMed ID: 20152237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease.
    Rocca B; Rubboli A; Zaccardi F
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):92-105. PubMed ID: 31766921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.
    Angiolillo DJ; Roffi M; Fernandez-Ortiz A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):697-710. PubMed ID: 21714601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.